Last reviewed · How we verify
NCT07149740
Data Gathering for A10900
trial testing OCT in Retinal Disease in 180 participants. Currently enrolling.
1 May 2026
Quick facts
| Lead sponsor | Optos, PLC |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 180 |
| Start date | 26 June 2025 |
| Primary completion | 1 May 2026 |
| Estimated completion | 1 May 2026 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- OCT
Conditions studied
- Retinal Disease — all drugs for Retinal Disease →
- Healthy — all drugs for Healthy →
- Glaucoma — all drugs for Glaucoma →
- Corneal Diseases — all drugs for Corneal Diseases →
Sponsor
Optos, PLC
Who can join
22 and older, any sex, with Retinal Disease or Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07149740
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of OCT
Trials testing the same drug.
- NCT05135312 — Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging · Phase 4 · unknown
- NCT06442176 — Choroid In Coronary Artery Disease · completed
- NCT04356027 — FUnctional diagnoSIs of corONary Stenosis (FUSION) · completed
- NCT04610645 — Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer · completed
- NCT04375319 — OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS) · NA · unknown
Other recruiting trials for Retinal Disease
Currently open trials in the same condition.
- NCT06852963 — A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Parti · Phase 1, PHASE2 · recruiting
- NCT05699096 — Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anterior · recruiting
- NCT06289452 — Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis · EARLY_PHASE1 · active not recruiting
- NCT06520410 — Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries · Phase 4 · recruiting
- NCT06269666 — P200TxE Diseased Eye Image Collection · NA · recruiting
Other Optos, PLC trials
Trials by the same sponsor.
- NCT06305481 — Glaucoma Evaluation With the P200TE · NA · completed
- NCT06269666 — P200TxE Diseased Eye Image Collection · NA · recruiting
- NCT05844852 — P200TE US Reference Database Study · NA · active not recruiting
- NCT05532410 — Optic Disc Photograph Collection Study · NA · completed
- NCT05536401 — P200TE Agreement and Precision Study · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07149740 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Optos, PLC
- Last refreshed: 13 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07149740.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing